Molecular Cytogenetics: Market Research Report

Date: January 5, 2016
Pages: 208
Price:
US$ 4,950.00
Publisher: Global Industry Analysts, Inc
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: MDA575B4F62EN
Leaflet:

Download PDF Leaflet

Molecular Cytogenetics: Market Research Report
This report analyzes the worldwide markets for Molecular Cytogenetics in US$ Thousand by the following Technologies: Fluorescence In Situ Hybridization, Array-based Technology. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 27 companies including many key and niche players such as -
  • Abbott Molecular, Inc.
  • Agilent Technologies, Inc.
  • Affymetrix, Inc.
  • Applied Spectral Imaging
  • Biological Industries
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study
Definitions
Fluorescence In Situ Hybridization (FISH)
Select FISH Procedures in Use
3D-FISH
Cellular Compartment Analysis of Temporal Activity
Combined Binary Ratio-FISH
Cryo-FISH
Immuno-FISH
Quantum Dot-Conjugates-FISH
Array-based Technology
Array-based Comparative Genomic Hybridization (aCGH)

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW

Advanced Molecular Biology Techniques Broaden the Scope of Cytogenetics
Major Growth Drivers
Market Outlook
Nucleic Acid Diagnostics Market – An Overview
Molecular Cytogenetics Greatly Benefit Cancer Prognosis
Diverse Applications of FISH Technology in Oncology
Opportunity Indicators: Global Cancer Incidence on the Rise

Table 1. Worldwide Incidence of Cancer in Million: 2012, 2020 & 2030 (includes corresponding Graph/Chart)
Table 2. World Cancer Incidence by Geographic Region and Gender (2012): Number of New Cancer Cases Reported (in Thousands) for Asia-Oceania, Europe, North America, Latin America & the Caribbean, and Africa (includes corresponding Graph/Chart)
Table 3. New Cancer Cases in the World by Affected Site: 2012 (in Thousands) (includes corresponding Graph/Chart)
Table 4. Global Cancer Incidence by Income Group: 2012 (in Thousands) (includes corresponding Graph/Chart)

Increasing Significance of Cytogenetic Analysis in Genetic Disease Diagnosis
Array-based Technologies to Drive Significant Market Growth
Transition from FISH to Array Based Technologies: A Major Trend
Array-based CGH to Emerge as First Line Test for Clinical Diagnosis of Chromosomal Anomalies
Molecular Cytogenetics Find Increasing Penetration in Clinical Pathological Testing
Enhanced AP LIS a Must to Keep Pace with Advancing Molecular Cytogenetic Testing
Impact of Shifting Focus of Biopharmaceuticals from Research to Development on Microarray Technology
Next-Gen Sequencing to Challenge Microarray Technology in the Distant Future
Technological Innovations Set to Drive the Market
Role of Molecular Cytogenetics in Personalized Medicine
Improving Healthcare Expenditure Turbo Charges Demand

Table 5. Per-Capita Healthcare Expenditure in Select Regions (2013) (includes corresponding Graph/Chart)
Table 6. Top 20 Countries with the Highest Healthcare Spending as a Percentage of GDP (2012) (includes corresponding Graph/Chart)

Demographics Spell Growth Opportunities

Table 7. Percentage Breakdown of Global Population by Age Group: 2015, 2050, and 2100 (includes corresponding Graph/Chart)
Table 8. 60+ Years Individuals as a Percentage of Total Population in Major Countries Worldwide: 2015, 2050, and 2100 (includes corresponding Graph/Chart)

2. TECHNOLOGY OVERVIEW

A Preface to Cytogenetics
Basic Terms and Definitions in Molecular Biology
DNA and RNA
RNA (Ribose nucleic acid)
Chromosomes
Gene
Genotype
Phenotype
Haplotype
Karyotyping
Karyotype
Nick
Probe
Reporter Molecule
Copy Number
Copy Number Variation
Analysis of Copy Numbers Variations
Chromosomal Abnormalities in Human Beings
An Overview of Select Chromosomal Anomalies
Insertion
Deletion
Duplication
Rearrangement
Select Human Diseases/Abnormalities Arising due to Translocations
Molecular Cytogenetics: Definition and Scope
Application of Molecular Cytogenetics
Insight into Molecular Cytogenetics Techniques
Fluorescence in situ Hybridization (FISH)
What is In Situ Hybridization?
How is FISH Better than Conventional Techniques?
Fluorescence In Situ Hybridization: The Process
Probe Types and Application
Types of Probes
Common Methods of Probe Preparation
Nick Translation and Polymerase Chain Reaction (PCR)
Applications of FISH
Types of FISH
3D-FISH
ACM-FISH or Multicolor FISH
ArmFISH
Catalyzed Reporter Deposition-FISH
Cellular Compartment Analysis of Temporal Activity
Cytochalasin-B -FISH
Combined Binary Ratio-FISH
Chromosome Orientation And Direction FISH
Combinatorial Oligonucleotide -FISH
Comet-FISH
Cryo-FISH
Double-Fusion -FISH
DNA Breakage Detection -FISH
e-FISH
Fiber-FISH
Flow-FISH
Fusion-Signal FISH
Halo-FISH
Harlequin-FISH
Immuno-FISH
Locked Nucleic Acids-FISH
M-FISH
Multilocus-FISH
Premature Chromosome Condensation-FISH
Peptide Nucleic Acids-FISH
Novel FISH Technology to Detect Plague Bacillus
Quantitative-FISH
Quantum Dot-Conjugates-FISH
Rainbow-FISH
Reverse-FISH
Recognition of Individual Genes-FISH
Expression-FISH
RxFISH
Split-Signal FISH
Telomere-FISH/ Tissue-FISH/ Tyramide-FISH (T-FISH)
Zoo-FISH
Spectral Karyotyping (SKY) Technique
Mouse FISH - a New Development
Comparative Genomic Hybridization
CGH: The Process
CGH: Applications In Clinical Cytogenetics
Benefits of CGH Analysis in Clinical Genetics
Limitations of CGH
Advent of Microarray Technology
What are Microarrays?
Microarrays in Gene Expression Analysis
Microarrays in Comparative Genomic Hybridization
Principle Underlying aCGH
Low Resolution and High Resolution aCGH
ACGH: The Process
aCGH: Potential Uses and Limitations
Potential Advantages of aCGH could be summarized as below
Limitations of aCGH
Analytical and Post-analytical Limitations
Interpretation of Results
Applications of Acgh
A Review of Molecular Biology Techniques in Cytogenetics

3. PRODUCT LAUNCHES/APPROVALS

NeoGenomics Introduces NeoSITE Cervical assay to FISH Testing Menu
Oxford Gene Technology Expands Cytocell FISH Probe Portfolio
Applied Spectral Imaging Receives Approval for GenASIs HiPath Platform
Agilent Technologies Introduces OneSeq
Leica Biosystems and Affymetrix Launch ViewRNA eZ Assays on BOND RX Platform
Affymetrix and BioDiscovery Launch Cancer Research Software
AKESOgen Launches Cytogenomics Microarray Test
Oxford Gene Technology Launches CytoSure Consortium Cancer +SNP array

4. RECENT INDUSTRY ACTIVITY

Eurofins Scientific to Acquire Stake in Emory Genetics Laboratory
ESPERITE Acquires Inkaryo
Medivo Collaborates with NeoGenomics for Data Analytics
Affymetrix Enters into Agreement with CollabRx
Thermo Fisher Scientific Completes Acquisition of Life Technologies
Applied Spectral Imaging Signs Distribution Partnership with Biocare
Applied Spectral Imaging and BioDot Enter Into Marketing Agreement
Cancer Genetics Italia Enters into Distribution Agreement with Nikon Instruments S. p. A.
Applied Spectral Imaging Enters Into Agreement with WaveSense
Oxford Gene Technology Signs License Agreement with CCMC

5. FOCUS ON SELECT PLAYERS

Abbott Molecular, Inc. (US)
Agilent Technologies, Inc. (US)
Affymetrix, Inc. (US)
Applied Spectral Imaging (US)
Biological Industries (Israel)
Bio-Rad Laboratories, Inc. (US)
CytoTest, Inc. (US)
Cytognomix, Inc. (Canada)
Illumina, Inc. (US)
Leica Biosystems Nussloch GmbH (Germany)
Oxford Gene Technology (UK)
PerkinElmer, Inc. (US)
Roche NimbleGen, Inc. (US)
SciGene Corporation (US)
Thermo Fisher Scientific, Inc. (US)

6. GLOBAL MARKET PERSPECTIVE

Table 9. World Recent Past Current & Future Analysis for Molecular Cytogenetics Technologies by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 10. World Historic Review for Molecular Cytogenetics Technologies by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 11. World 14-Year Perspective for Molecular Cytogenetics Technologies by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

By Technology

Table 12. World Recent Past Current & Future Analysis for Fluorescence In Situ Hybridization (FISH) by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 13. World Historic Review for Fluorescence In Situ Hybridization (FISH) by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 14. World 14-Year Perspective for Fluorescence In Situ Hybridization (FISH) by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)
Table 15. World Recent Past Current & Future Analysis for Array-Based Technology by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 16. World Historic Review for Array-Based Technology by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 17. World 14-Year Perspective for Array-Based Technology by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

A. Market Analysis
Market Trends
aCGH to Predominate the Technological Front in Molecular Cytogenetics in Future
Revised ACMG Guidelines to Accelerate Use of aCGH Over FISH
The Clinical Sector: A Potential Market Opportunity for Array-based Technologies
FISH in the Cancer Diagnostics Scenario in the US
Market Restraints
Immunohistochemical (IHC) Tests: The Most Recommended Diagnostic Test for Cancers
Factors Limiting the Growth of FISH Technology in Cancer Diagnostics
FISH in Diagnosis of Bladder Carcinoma
FISH in Breast Cancer Diagnosis
Cancer Statistics – Opportunity Indicator

Table 18. New Cancer Cases in the US by Gender and Affected Site: 2014E (includes corresponding Graph/Chart)
Table 19. Incidence of Cancer for All Body Sites by Gender & Age Group in the US (2013): New Cancer Cases for Males & Females for the Age groups Under 45 years; 45 years and Above; Under 65 years; 65 years and Above (includes corresponding Graph/Chart)
Table 20. The US Breast Cancer Incidence in Women by State (2013): New Cases of Breast Cancer in Leading 15 States (includes corresponding Graph/Chart)

Product Launches
Strategic Corporate Developments
Focus on Select Major Players
B. Market Analytics

Table 21. The US Recent Past Current & Future Analysis for Molecular Cytogenetics by Technology Type - Fluorescence in Situ Hybridization and Array-based Technology Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 22. The US Historic Review for Molecular Cytogenetics by Technology Type - Fluorescence in Situ Hybridization and Array-based Technology Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 23. The US 14-Year Perspective for Molecular Cytogenetics by Technology Type - Percentage Breakdown of Dollar Sales for Fluorescence in Situ Hybridization and Array-based Technology Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

2. CANADA

A. Market Analysis
Cancer Statistics in Canada: Opportunity Indicator

Table 24. New Cancer Cases in Canada by Gender and Affected Site: 2014E (includes corresponding Graph/Chart)
Table 25. New Cancer Cases in Canada by Province: 2014E (includes corresponding Graph/Chart)
Table 26. New Cancer Cases in Canada by Age Group: 2014E (includes corresponding Graph/Chart)

Cytognomix Inc. – A Key Canadian Player
B. Market Analytics

Table 27. Canadian Recent Past Current & Future Analysis for Molecular Cytogenetics by Technology Type - Fluorescence in Situ Hybridization and Array-based Technology Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 28. Canadian Historic Review for Molecular Cytogenetics by Technology Type - Fluorescence in Situ Hybridization and Array-based Technology Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 29. Canadian 14-Year Perspective for Molecular Cytogenetics by Technology Type - Percentage Breakdown of Dollar Salesfor Fluorescence in Situ Hybridization and Array-based Technology Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

3. JAPAN

Market Analysis

Table 30. Japanese Recent Past Current & Future Analysis for Molecular Cytogenetics by Technology Type - Fluorescence in Situ Hybridization and Array-based Technology Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 31. Japanese Historic Review for Molecular Cytogenetics by Technology Type - Fluorescence in Situ Hybridization and Array-based Technology Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 32. Japanese 14-Year Perspective for Molecular Cytogenetics by Technology Type - Percentage Breakdown of Dollar Sales for Fluorescence in Situ Hybridization and Array-based Technology Markets for Years 009, 2016 & 2022 (includes corresponding Graph/Chart)

4. EUROPE

A. Market Analysis
Cancer Statistics in Europe

Table 33. Number of New Cancer Cases in Europe: 2012-2030 (includes corresponding Graph/Chart)

B. Market Analytics

Table 34. European Recent Past Current & Future Analysis for Molecular Cytogenetics by Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 35. European Historic Review for Molecular Cytogenetics by Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 36. European 14-Year Perspective for Molecular Cytogenetics by Region - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)
Table 37. European Recent Past Current & Future Analysis for Molecular Cytogenetics by Technology Type - Fluorescence in Situ Hybridization and Array-based Technology Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 38. European Historic Review for Molecular Cytogenetics by Technology Type - Fluorescence in Situ Hybridization and Array-based Technology Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 39. European 14-Year Perspective for Molecular Cytogenetics Market by Technology Type - Percentage Breakdown of Dollar Sales for Fluorescence in Situ Hybridization and Array-based Technology Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

4A. FRANCE

Market Analysis

Table 40. French Recent Past Current & Future Analysis for Molecular Cytogenetics by Technology Type - Fluorescence in Situ Hybridization and Array-based Technology Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 41. French Historic Review for Molecular Cytogenetics by Technology Type - Fluorescence in Situ Hybridization and Array-based Technology Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 42. French 14-Year Perspective for Molecular Cytogenetics Market by Technology Type - Percentage Breakdown of Dollar Sales for Fluorescence in Situ Hybridization and Array-based Technology Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

4B. GERMANY

A. Market Analysis
Leica Biosystems Nussloch GmbH – A Key Germany-based Player
B. Market Analytics

Table 43. German Recent Past Current & Future Analysis for Molecular Cytogenetics by Technology Type - Fluorescence in Situ Hybridization and Array-based Technology Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 44. German Historic Review for Molecular Cytogenetics by Technology Type - Fluorescence in Situ Hybridization and Array-based Technology Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 45. German 14-Year Perspective for Molecular Cytogenetics by Technology Type - Percentage Breakdown of Dollar Sales for Fluorescence in Situ Hybridization and Array-based Technology Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

4C. ITALY

A. Market Analysis
Strategic Corporate Development
B. Market Analytics

Table 46. Italian Recent Past Current & Future Analysis for Molecular Cytogenetics by Technology Type - Fluorescence in Situ Hybridization and Array-based Technology Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 47. Italian Historic Review for Molecular Cytogenetics by Technology Type - Fluorescence in Situ Hybridization and Array-based Technology Independently Markets Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 48. Italian 14-Year Perspective for Molecular Cytogenetics by Technology Type - Percentage Breakdown of Dollar Sales for Fluorescence in Situ Hybridization and Array-based Technology Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

4D. THE UNITED KINGDOM

A. Market Analysis
Product Launch
Strategic Corporate Development
Oxford Gene Technology – A Key UK-Based Player
B. Market Analytics

Table 49. The United Kingdom Recent Past Current & Future Analysis for Molecular Cytogenetics by Technology Type - Fluorescence in Situ Hybridization and Array-based Technology Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 50. The United Kingdom Historic Review for Molecular Cytogenetics by Technology Type - Fluorescence in Situ Hybridization and Array-based Technology Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 51. The United Kingdom 14-Year Perspective for Molecular Cytogenetics by Technology Type - Percentage Breakdown of Dollar Sales for Fluorescence in Situ Hybridization and Array-based Technology Markets for Years 2009, 2016 & 2022 (includes correspondingGraph/Chart)

4E. SPAIN

Market Analysis

Table 52. Spanish Recent Past Current & Future Analysis for Molecular Cytogenetics by Technology Type - Fluorescence in Situ Hybridization and Array-based Technology Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 53. Spanish Historic Review for Molecular Cytogenetics by Technology Type - Fluorescence in Situ Hybridization and Array-based Technology Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 54. Spanish 14-Year Perspective for Molecular Cytogenetics Market by Technology Type - Percentage Breakdown of Dollar Sales for Fluorescence in Situ Hybridization and Array-based Technology Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

4F. RUSSIA

Market Analysis

Table 55. Russian Recent Past Current & Future Analysis for Molecular Cytogenetics by Technology Type - Fluorescence in Situ Hybridization and Array-based Technology Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 56. Russian Historic Review for Molecular Cytogenetics by Technology Type - Fluorescence in Situ Hybridization and Array-based Technology Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 57. Russian 14-Year Perspective for Molecular Cytogenetics by Technology Type - Percentage Breakdown of Dollar Sales for Fluorescence in Situ Hybridization and Array-based Technology Markets for Years 2009,2016 & 2022 (includes corresponding Graph/Chart)

4G. REST OF EUROPE

A. Market Analysis
Strategic Corporate Developments
B. Market Analytics

Table 58. Rest of Europe Recent Past Current & Future Analysis for Molecular Cytogenetics by Technology Type - Fluorescence in Situ Hybridization and Array-based Technology Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 59. Rest of Europe Historic Review for Molecular Cytogenetics by Technology Type - Fluorescence in Situ Hybridization and Array-based Technology Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 60. Rest of Europe 14-Year Perspective for Molecular Cytogenetics by Technology Type - Percentage Breakdown of Dollar Sales for Fluorescence in Situ Hybridization and Array-based Technology Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

Market Analysis

Table 61. Asia-Pacific Recent Past Current & Future Analysis for Molecular Cytogenetics by Region - China, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 62. Asia-Pacific Historic Review for Molecular Cytogenetics by Region - China, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 63. Asia-Pacific 14-Year Perspective for Molecular Cytogenetics by Region - Percentage Breakdown of Dollar Sales for China and Rest of Asia-Pacific Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)
Table 64. Asia-Pacific Recent Past Current & Future Analysis for Molecular Cytogenetics by Technology Type - Fluorescence in Situ Hybridization and Array-based Technology Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 65. Asia-Pacific Historic Review for Molecular Cytogenetics by Technology Type - Fluorescence in Situ Hybridization and Array-based Technology Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 66. Asia-Pacific 14-Year Perspective for Molecular Cytogenetics by Technology Type - Percentage Breakdown of Dollar Sales for Fluorescence in Situ Hybridization and Array-based Technology Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

5A. CHINA

A. Market Analysis
China: A Potential Market for FISH Technology in Clinical Diagnostics
B. Market Analytics

Table 67. Chinese Recent Past Current & Future Analysis for Molecular Cytogenetics by Technology Type - Fluorescence in Situ Hybridization and Array-based Technology Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 68. Chinese Historic Review for Molecular Cytogenetics by Technology Type - Fluorescence in Situ Hybridization and Array-based Technology Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 69. Chinese 14-Year Perspective for Molecular Cytogenetics by Technology Type - Percentage Breakdown of Dollar Sales for Fluorescence in Situ Hybridization and Array-based Technology Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

5B. REST OF ASIA-PACIFIC

A. Market Analysis
An Insight into the Indian Microarray Market
Product Launch
B. Market Analytics

Table 70. Rest of Asia-Pacific Recent Past Current & Future Analysis for Molecular Cytogenetics by Technology Type - Fluorescence in Situ Hybridization and Array-based Technology Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 71. Rest of Asia-Pacific Historic Review for Molecular Cytogenetics by Technology Type - Fluorescence in Situ Hybridization and Array-based Technology Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 72. Rest of Asia-Pacific 14-Year Perspective for Molecular Cytogenetics by Technology Type - Percentage Breakdown of Dollar Sales for Fluorescence in Situ Hybridization and Array-based Technology Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

6. REST OF WORLD

A. Market Analysis
Biological Industries – A Key Israel-based Player
B. Market Analytics

Table 73. Rest of World Recent Past Current & Future Analysis for Molecular Cytogenetics by Technology Type - Fluorescence in Situ Hybridization and Array-based Technology Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 74. Rest of World Historic Review for Molecular Cytogenetics by Technology Type - Fluorescence in Situ Hybridization and Array-based Technology Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 75. Rest of World 14-Year Perspective for Molecular Cytogenetics by Technology Type - Percentage Breakdown of Dollar Sales for Fluorescence in Situ Hybridization and Array-based Technology Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 27 (including Divisions/Subsidiaries - 28)
The United States (20)
Canada (1)
Europe (6)
  Germany (2)
  The United Kingdom (1)
  Rest of Europe (3)
Asia-Pacific (Excluding Japan) (1)
Skip to top


Ask Your Question

Molecular Cytogenetics: Market Research Report
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: